Read our latest blog on the evolution and challenges of translational science in #Oncology research. synexagroup.com/blog-article…

In our latest blog, Nicholas Woudberg explores the risks of cardiovascular complications associated with chronic kidney disease. #Synexa #lifesciences #WorldKidneyDay #worldkidneyday2024 l1nq.com/awDJB

In our latest video, Sinead Robberts shares how Synexa harnesses the cutting-edge Olink® Target to provide advanced #biomarker analysis and discovery to customers. Drive your biomarker development and innovation: lnkd.in/ezh3UNQa @OlinkProteomics youtube.com/watch?v=jofZRT74…

Happy #InternationalWomensDay from us at Synexa! Today, we would like to celebrate the invaluable achievements of women in science and leadership. Their inspiration, expertise and insights are pivotal to our success and purpose in improving the quality of human health.

The 29th of February 2024 marks the global observance of Rare Disease Day. On this leap day, we delve into Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). synexagroup.com/blog-article… #rarediseaseday #RareDisease

Synexa will be at the hubXchange Antibody Therapeutics & Immuno-oncology events next Monday and Tuesday in San Diego! #Synexa #lifesciences #hubxchange #biomarker #bioanalysis

Limited treatment for minorities affects all cancer types. In this article we explore how vast this gap is, understand inequality in cancer treatment/research, and discuss ways we can continue to address this issue. synexagroup.com/blog-article… #WorldCancerDay

#WorldLeprosyDay is observed on the last Sunday of January each year, aiming to raise awareness about leprosy and teach people about this ancient disease that is easily curable today.  Read: synexagroup.com/blog-article… #Synexa #lifesciences #leprosy #biomarkers #bioanalysis

This maternal health awareness week we discuss pre-eclampsia, a condition that affects up to 8% of pregnancies worldwide. synexagroup.com/blog-article… #maternalhealth #Synexa #lifesciences #pregnancy

As we step into 2024, Nicholas Woudberg, Head of Scientific Strategies. shares his top 3 trends we can expect to see more of this year in the pharma and biotech industry. synexagroup.com/blog-article… #Synexa #lifesciences #pharma #biotech #trends

Our latest blog dives into the cutting-edge methodology of Seed Amplification Assays (SAA) in detecting α-synuclein aggregates—a potential prognostic biomarker for Parkinson's Disease. Read here: synexagroup.com/blog-article… #Synexa #lifesciences #disease

Pre-Analytical Considerations for Vaccine Studies Watch a snippet from our latest webinar as we discuss important considerations in vaccine study setup including sample stability, handling, processing and storage. Watch the full webinar here:  lnkd.in/ewcxqcaF

Lung cancer is one of the most common cancers worldwide, and the leading cause of cancer-related deaths. Today, on World #LungCancer Day, Dr. Frank Kirstein explores the role of CAR T Therapy in treating Lung Cancer. Read below: lnkd.in/epuKM9Zc #Synexa #lungcancer

On this World Hepatitis Day, Dr. Caroline Beltran investigates the various types of biomarkers which can be used to further our understanding of Autoimmune Hepatitis (AIH), a rare form of the disease. Read below: synexagroup.com/blog-article… #Synexa #hepatitis #biomarkers

Explore the revolutionary world of liquid biopsies in our latest blog post by Nicholas Woudberg. Discover how this non-invasive method is transforming cancer care by providing a comprehensive picture of cancer physiology. Read more: lnkd.in/ei-bM-KV #oncology

Thank you to Thomas Scriba, Deputy Director of Immunology at South African Tuberculosis Vaccine Initiative (SATVI) for joining Synexa earlier this week for our TB Vaccine Development webinar. Watch on-demand: xtalks.com/webinars/accelera…